Alfresa Holdings Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALFRY research report →
About the company
Tokyo, Japan-based Alfresa Holdings Corporation, established in 2003, is a diversified entity operating domestically and internationally within the healthcare industry. The company's core activities encompass the production, wholesale distribution, marketing, and global trade of pharmaceuticals, diagnostic agents, and medical equipment. Alfresa operates through distinct wholesale divisions, including an ethical pharmaceuticals segment that supplies hospitals, clinics, and pharmacies with essential diagnostic reagents, medical devices, and prescription drugs.
- CEO
- Ryuji Arakawa
- IPO
- 2018
- Employees
- 12,517
- HQ
- Tokyo, JP
Price Chart
- Market Cap
- $2.51B
- P/E
- 9.48
- P/S
- 0.13
- P/B
- 0.78
- EV/EBITDA
- 3.08
- Div Yield
- 3.12%
- Gross Margin
- 7.02%
- Op Margin
- 1.17%
- Net Margin
- 1.34%
- ROE
- 8.48%
- ROIC
- 4.28%
- Revenue
- $3.29T · 11.15%
- Net Income
- $44.26B · 61.61%
- EPS
- $242.87 · 64.61%
- Op Income
- $38.19B
- FCF YoY
- 257.15%
- 52W High
- $16.81
- 52W Low
- $12.42
- 50D MA
- $14.39
- 200D MA
- $15.22
- Beta
- -0.16
- Avg Volume
- 138
Get TickerSpark's AI analysis on ALFRY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ALFRY coverage
Recent articles, reports, and earnings notes.
No research on ALFRY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALFRY report →Similar companies
Peers in the same neighborhood.